- ADMA +27.13%
Search results
- 8.81Add to watchlist+1.88 (+27.13%)At close: Fri. May 10, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open8.20High9.02Low7.96
- Mkt Cap2.04BP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close6.9352 Wk. Low3.0652 Wk. High9.02
Top storiesADMA Biologics First Quarter 2024 Earnings: Beats ExpectationsYahoo Finance · 20 hours ago- ADMA +27.13%
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call TranscriptYahoo Finance · 2 days agoAdma Biologics (ADMA) Surpasses Q1 Earnings and Revenue EstimatesYahoo Finance · 2 days agoRelated stocks
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious ...
- Historical Data
Discover historical prices for ADMA stock on Yahoo Finance....
- Options
View the basic ADMA option chain and compare options of ADMA...
- Analysis
See ADMA Biologics, Inc. (ADMA) stock analyst estimates,...
- Profile
ADMA Biologics, Inc. was incorporated in 2004 and is...
- Stock Forum & Discussion
Find the latest ADMA Biologics, Inc. (ADMA) stock discussion...
- Historical Data
Get the latest investor information on ADMA Biologics, including press releases, quarterly earnings, stock information, and more. ADMA Biologics is an end-to-end commercial biopharmaceutical company leading a new age of plasma-derived products with proven immunotechnology.
Get the latest ADMA Biologics Inc (ADMA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
People also ask
Who is ADMA biologics?
What does ADMA stand for?
Does ADMA biopharmaceutical work?
What is the corporate segment of ADMA biologics?
3 days ago · 0.44%. $9.33B. ADMA | Complete ADMA Biologics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
May 2, 2024 · A high-level overview of ADMA Biologics, Inc. (ADMA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the ...
6 days ago · ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update. 1Q 2024 Total Revenue of $81.9 Million, a 44% Increase Y-o-Y 1Q 2024 GAAP Net Income of $17.8 Million, a $24.6 Million Increase Y-o-Y 1Q 2024 Adjusted EBITDA ( 1) of $26.4 Million, a 970% Increase Y-... 1 day ago - GlobeNewsWire.